TTD | Drug: D0Q1GL

Drug General Information
Drug ID	D0Q1GL
Former ID	DIB002766
Drug Name	CT-200
Indication	Cancer [ICD9: 140-229; ICD10:C00-C96]		Phase 1	[548651]
Company	Celleron Therapeutics
Target and Pathway
Target(s)	Histone deacetylase	Target Info	Inhibitor	[549783]
References
Ref 548651	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027375)
Ref 549783	Clinical pipeline report, company report or official report of Celleron.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information